Arrowstreet Capital, Limited Partnership Halozyme Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$108 Billion
Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 6,899 shares of HALO stock, worth $361,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,899

Holding current value

$361,231

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $232,358 - $289,413	6,899 New	6,899 $281,000
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $3.69 Million - $4.46 Million	101,211 New	101,211 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $4.33 Million - $5.82 Million	112,414 Added 70.61%	271,615 $10.7 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $5.95 Million - $7.69 Million	159,201 New	159,201 $7.01 Million
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $13.2 Million - $17 Million	-416,140 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $16 Million - $19.3 Million	416,140 New	416,140 $16.9 Million
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $1.64 Million - $2.77 Million	-63,400 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $1.31 Million - $1.51 Million	50,916 Added 407.85%	63,400 $1.67 Million
Q2 2020 Aug 12, 2020	SELL	$16.25 - $26.81 $1.49 Million - $2.46 Million	-91,613 Reduced 88.01%	12,484 $335,000
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $3.92 Million - $6.16 Million	-282,144 Reduced 73.05%	104,097 $1.87 Million
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $4.14 Million - $5.42 Million	277,395 Added 254.85%	386,241 $6.85 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $1.65 Million - $1.93 Million	108,846 New	108,846 $1.69 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $959,561 - $1.12 Million	-65,055 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $906,866 - $1.14 Million	65,055 New	65,055 $1.05 Million
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $8.13 Million - $9.78 Million	-481,718 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$17.06 - $21.2 $8.22 Million - $10.2 Million	481,718 New	481,718 $9.44 Million

Others Institutions Holding HALO

# of Institutions

441

Shares Held

122M

Call Options Held

216K

Put Options Held

140K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.29B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Halozyme Therapeutics, Inc. Transaction History